Abstract
The Gram-positive bacteria S. aureus and group A streptococci (GAS) are common causes of colonization or infection. Diseases associated with S. aureus infection range from superficial skin infections, such as impetigo and furuncles, at one end of the spectrum to pyogenic abscesses, endocarditis, bone and joint infection, and toxic shock syndrome (TSS) at the other extreme. Similarly, infection with GAS ranges from pharyngitis to streptococcal toxic shock-like syndrome (TSLS) (Cunningham, 2000).
Keywords
- Kawasaki Disease
- Kawasaki Disease Patient
- Versus Beta
- Kawasaki Syndrome
- Streptococcal Toxic Shock Syndrome
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abe, J., Kotzin, B.L., Jujo, K., Melish, M.E., Glode, M.P., Kohsaka, T. et al. (1992). Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc. Natl. Acad. Sci. USA 89(9), 4066–4070.
Abe, J., Kotzin, B.L., Meissner, C., Melish, M.E., Takahashi, M., Fulton, D. et al. (1993). Characterization of T cell repertoire changes in acute Kawasaki disease. J. Exp. Med. 177(3), 791–796.
Biezeveld, M.H., Kuipers, I.M., Geissler, J., Lam, J., Ottenkamp, J.J., Hack, C.E. et al. (2003). Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease. Lancet 361(9365), 1268–1270.
Brogan, P.A., Bose, A., Burgner, D., Shingadia, D., Tulloh, R., Michie, C. et al. (2002). Kawasaki disease: An evidence based approach to diagnosis, treatment, and proposals for future research. Arch. Dis. Child. 86(4), 286–290.
Brogan, P.A., Shah, V., Bagga, A., Klein, N., and Dillon, M.J. (2003). T cell Vbeta repertoires in childhood vasculitides. Clin. Exp. Immunol. 131(3), 517–527.
Choi, I.H., Chwae, Y.J., Shim, W.S., Kim, D.S., Kwon, D.H., Kim, J.D. et al. (1997). Clonal expansion of CD8 + T cells in Kawasaki disease. J. Immunol. 159(1), 481–486.
Choi, Y., Lafferty, J.A., Clements, J.R., Todd, J.K., Gelfand, E.W., Kappler, J. et al. (1990). Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J. Exp. Med. 172(3), 981–984.
Cunningham, M.W. (2000). Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13(3), 470–511.
Curtis, N., Chan, B., and Levin, M. (1994). Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 343(8892), 299.
Curtis, N. and Levin, M. (1998). Kawasaki disease thirty years on. Curr. Opin. Pediatr. 10(1), 24–33.
Curtis, N., Zheng, R., Lamb, J.R., and Levin, M. (1995). Evidence for a superantigen mediated process in Kawasaki disease. Arch. Dis. Child. 72(4), 308–311.
Darenberg, J., Ihendyane, N., Sjolin, J., Aufwerber, E., Haidl, S., Follin, P. et al. (2003). Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 37(3), 333–340.
Davies, H.D., Kirk, V., Jadavji, T., and Kotzin, B.L. (1996). Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr. Infect. Dis. J. 15(12), 1136–1138.
De Inocencio, J. and Hirsch, R. (1995). Evidence for superantigen mediated process in Kawasaki disease. Arch. Dis. Child. 73(3), 275–276.
Duong, T.T., Silverman, E.D., Bissessar, M.V., and Yeung, R.S. (2003). Superantigenic activity is responsible for induction of coronary arteritis in mice: An animal model of Kawasaki disease. Int. Immunol. 15(1), 79–89.
Fraser, J., Arcus, V., Kong, P., Baker, E., and Proft, T. (2000). Superantigens—powerful modifiers of the immune system. Mol. Med. Today 6(3), 125–132.
Herbert, S., Barry, P., and Novick, R.P. (2001). Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect. Immun. 69(5), 2996–3003.
Kaul, R., McGeer, A., Norrby-Teglund, A., Kotb, M., Schwartz, B., O’Rourke, K. et al. (1999). Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome—a comparative observational study. The Canadian Streptococcal Study Group. Clin. Infect. Dis. 28(4), 800–807.
Kotzin, B.L., Leung, D.Y., Kappler, J., and Marrack, P. (1993). Superantigens and their potential role in human disease. Adv. Immunol. 54, 99–166.
Leung, D.Y., Giorno, R.C., Kazemi, L.V., Flynn, P.A., and Busse, J.B. (1995). Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J. Immunol. 155(10), 5018–5021.
Leung, D.Y., Meissner, H.C., Fulton, D.R., Murray, D.L., Kotzin, B.L., and Schlievert, P.M. (1993). Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 342(8884), 1385–1388.
Leung, D.Y., Meissner, H.C., Shulman, S.T., Mason, W.H., Gerber, M.A., Glode, M.P. et al. (2002). Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J. Pediatr. 140(6), 742–746.
Leung, D.Y., Sullivan, K.E., Brown-Whitehorn, T.F., Fehringer, A.P., Allen, S., Finkel, T.H. et al. (1997). Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease. Pediatr. Res. 42(3), 268–272.
Levin, M., Tizard, E.J., and Dillon, M.J. (1991). Kawasaki disease: Recent advances. Arch. Dis. Child. 66(12), 1369–1372.
Llewelyn, M. and Cohen, J. (2002). Superantigens: Microbial agents that corrupt immunity. Lancet Infect. Dis. 2(3), 156–162.
Mancia, L., Wahlstrom, J., Schiller, B., Chini, L., Elinder, G., D’Argenio, P. et al. (1998). Characterization of the T-cell receptor V-beta repertoire in Kawasaki disease. Scand. J. Immunol. 48(4), 443–449.
Marrack, P. and Kappler, J. (1990). The staphylococcal enterotoxins and their relatives. Science 248(4959), 1066.
Masuda, K., Takei, S., Nomura, Y., Imanaka, H., Sameshima, K., and Yoshinaga, M. (1998). Transient low T cell response to streptococcal pyrogenic exotoxin-C in patients with Kawasaki disease. Pediatr. Res. 44(1), 27–31.
Matsuda, Y., Kato, H., Yamada, R., Okano, H., Ohta, H., Imanishi, K. et al. (2003). Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor VBeta2-positive T cells. Emerg. Infect. Dis. 9(3), 387–389.
Meissner, H.C. and Leung, D.Y. (2000). Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr. Infect. Dis. J. 19(2), 91–94.
Melish, M.E. (1992). Kawasaki syndrome: A 1992 update. Pediatr. Dermatol. 9(4), 335–337.
Nakano, T., Hiramatsu, K., Kishi, K., Hirata, N., Kadota, J., and Nasu, M. (2003). Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages. Antimicrob. Agents Chemother. 47(1), 363–367.
Nomura, Y., Masuda, K., Shinkoda, Y., Sameshima, K., Oku, S., Yoshinaga, M. et al. (1998). Twenty-five types of T-cell receptor Vbeta family repertoire in patients with Kawasaki syndrome. Eur. J. Pediatr. 157(12), 981–986.
Nomura, Y., Yoshinaga, M., Masuda, K., Takei, S., and Miyata, K. (2002). Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome. J Infect. Dis. 185(11), 1677–1680.
Ouchi, K., Suzuki, Y., Shirakawa, T., and Kishi, F. (2003). Polymorphism of SLC11A1 (formerly NRAMP1) gene confers susceptibility to Kawasaki disease. J. Infect. Dis. 187(2), 326–329.
Pietra, B.A., De Inocencio, J., Giannini, E.H., and Hirsch, R. (1994). TCR V beta family repertoire and T cell activation markers in Kawasaki disease. J. Immunol. 153(4), 1881–1888.
Quasney, M.W., Bronstein, D.E., Cantor, R.M., Zhang, Q., Stroupe, C., Shike, H. et al. (2001). Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr. Res. 49(5), 686–690.
Reichardt, P., Lehmann, I., Sierig, G., and Borte, M. (2002). Analysis of T-cell receptor V-beta 2 in peripheral blood lymphocytes as a diagnostic marker for Kawasaki disease. Infection 30(6), 360–364.
Rowley, A.H. (1999). The etiology of Kawasaki disease: Superantigen or conventional antigen? Pediatr. Infect. Dis. J. 18(1), 69–70.
Rowley, A.H. and Shulman, S.T. (1999). Kawasaki syndrome. Pediatr. Clin. North Am. 46(2), 313–329.
Sakaguchi, M., Kato, H., Nishiyori, A., Sagawa, K., and Itoh, K. (1995). Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): Preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2-or V beta 8-CD4+ T helper cells. Clin. Exp. Immunol. 99(2), 276–282.
Sriskandan, S., McKee, A., Hall, L., and Cohen, J. (1997). Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes. J. Antimicrob. Chemother. 40(2), 275–277.
Stevens, D.L. (2002). Streptococcal toxic shock syndrome. Clin. Microbiol. Infect. 8(3), 133–136.
Terai, M., Miwa, K., Williams, T., Kabat, W., Fukuyama, M., Okajima, Y. et al. (1995). The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J. Infect. Dis. 172(2), 558–561.
Todd, J.K. (1988). Toxic shock syndrome. Clin. Microbiol. Rev. 1(4), 432–446.
Todome, Y., Ohkuni, H., Mizuse, M., Okibayashi, F., Ohtani, N., Suzuki, H. et al. (1995). Superantigenic exotoxin production by isolates of Staphylococcus aureus from the Kawasaki syndrome patients and age-matched control children. J. Med. Microbiol. 42(2), 91–95.
Yamashiro, Y., Nagata, S., Oguchi, S., and Shimizu, T. (1996). Selective increase of V beta 2+ T cells in the small intestinal mucosa in Kawasaki disease. Pediatr. Res. 39(2), 264–266.
Yoshioka, T., Matsutani, T., Iwagami, S., Toyosaki-Maeda, T., Yutsudo, T., Tsuruta, Y. et al. (1999). Polyclonal expansion of TCRBV2-and TCRBVö-bearing T cells in patients with Kawasaki disease. Immunology 96(3), 465–472.
Yoshioka, T., Matsutani, T., Toyosaki-Maeda, T., Suzuki, H., Uemura, S., Suzuki, R. et al. (2003). Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease. Pediatr. Res. 53(3), 403–110.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Science+Business Media New York
About this paper
Cite this paper
Curtis, N. (2004). Kawasaki Disease and Toxic Shock Syndrome—At Last the Etiology is Clear?. In: Pollard, A.J., McCracken, G.H., Finn, A. (eds) Hot Topics in Infection and Immunity in Children. Advances in Experimental Medicine and Biology, vol 549. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8993-2_26
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8993-2_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4751-4
Online ISBN: 978-1-4419-8993-2
eBook Packages: Springer Book Archive